Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploring RNA interference as a therapeutic strategy for renal disease.

Y Takabatake1, Y Isaka, M Mizui

  • 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine (A8), Suita, Japan.

Gene Therapy
|February 25, 2005
PubMed
Summary

Synthetic short interfering RNA (siRNA) effectively silences gene expression in kidney cells. This approach shows therapeutic potential for treating fibrotic diseases like glomerulonephritis by targeting TGF-beta1.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In response to "Obstetric anesthesia in Japan: an existential crisis in need of an intervention".

International journal of obstetric anesthesia·2025
Same author

Plasma CD147 reflects histological features in patients with lupus nephritis.

Lupus·2014
Same author

Longitudinal distortions and transversal fluctuations of an actin filament sliding on Myosin molecules.

Journal of biological physics·2013
Same author

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

Diabetologia·2011
Same author

Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes.

Diabetologia·2011
Same author

FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial.

Journal of dental research·2010

Area of Science:

  • Molecular Biology
  • Renal Physiology
  • RNA Interference Therapeutics

Background:

  • Short interfering RNA (siRNA) selectively suppresses gene expression in mammalian cells.
  • Selective in vivo delivery of siRNA to the kidney remains a challenge.
  • Gene silencing in glomerular cells is crucial for treating kidney diseases.

Purpose of the Study:

  • To investigate the efficacy and therapeutic potential of intra-arterial siRNA delivery combined with electroporation for gene silencing in rat kidneys.
  • To compare the potency of siRNA with antisense oligodeoxynucleotide (ASODN) in mesangial cells.
  • To evaluate the therapeutic effect of targeting TGF-beta1 in experimental glomerulonephritis.

Main Methods:

  • siRNA transfection into cultured rat mesangial cells (MCs).

Related Experiment Videos

  • Intra-arterial delivery of siRNA targeting luciferase and enhanced green fluorescent protein (EGFP) in rat kidneys.
  • In vivo assessment of gene silencing via luciferase and EGFP expression.
  • RNA interference (RNAi) targeting TGF-beta1 in an experimental glomerulonephritis model.

    • Main Results:

    • siRNA demonstrated over 1000-fold greater potency than ASODN in suppressing transgene expression in MCs.
    • siRNA targeting luciferase significantly inhibited its expression in rat kidneys.
    • EGFP expression was reduced in glomerular MCs of transgenic rats following siRNA delivery.
    • RNAi targeting TGF-beta1 suppressed both mRNA and protein levels, ameliorating matrix expansion in glomerulonephritis.

    Conclusions:

    • Intra-arterial siRNA delivery with electroporation is an effective method for gene silencing in the kidney glomerulus.
    • siRNA-directed TGF-beta1 silencing holds therapeutic promise for fibrotic kidney diseases.
    • Vector-based RNAi also proved effective in inhibiting TGF-beta1 expression in vitro and in vivo.